4//SEC Filing
AYCARDI-FONSECA ERNESTO 4
Accession 0001209191-20-018958
CIK 0001582313other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:06 PM ET
Size
5.3 KB
Accession
0001209191-20-018958
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 totalExercise: $11.58Exp: 2030-03-11→ Common Shares (65,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001734218
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:06 PM ET
- Size
- 5.3 KB